期刊文献+

肺动脉高压的急性血管反应试验

Acute Vasoreactivity Testing in Pulmonary Hypertension
下载PDF
导出
摘要 急性血管反应试验对指导肺动脉高压患者的治疗是重要的,它可以选择出适合长期钙通道阻滞剂治疗的患者,判断患者预后。目前用于急性血管反应试验的药物主要有前列环素、腺苷、一氧化氮。肺动脉高压患者进行急性血管反应试验可能产生严重不良反应,应在持续监测的情况下由有经验的人员完成。 Acute vasoreactivity testing is essential to the treatment of patients with pulmonary hypertension. It can help to identify patients who can benefit from long-term treatment with calcium channel blockers, and determine a patient' s prognosis. Drugs currently used in acute vasoreactivity test are mainly prostacycline, adenosine, and nitric oxide. Acute vasoreactivity testing can cause severe adverse effects in patients with pulmonary hypertension, and therefore must be undertaken by experienced practitioners under continuous monitoring.
出处 《心血管病学进展》 CAS 2008年第5期681-683,共3页 Advances in Cardiovascular Diseases
关键词 肺动脉高压 急性血管反应试验 钙通道阻滞剂 pulmonary hypertension acute vasoreactivity test calcium channel blocker
  • 相关文献

参考文献8

  • 1Galie N, Torbieki A, Barst R, et al. The task force on diagnosis and treatment of puhnonary arterial hypertension of the European Society of Cardiology. Guidelines on diagnosis and treatment of pulmonary arterial hypertension [ J ]. Eur Heart J,2004,25 (24) : 2243 -2278.
  • 2Galie N, Ussia G, Passarelli P, et al. Role of pharmacologic tests in the treatment of primary pulmonary hypertension [ J]. Am J Cardiol, 1995,75 (3) :55A-652A.
  • 3Opitz CF,Wensel R, Bettmann M, et al. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyelin and iloprost administered by either infusion or inhalation [ J ]. Eur Heart J,2003,24 (4) :356-365.
  • 4Badesch DB, Abman SH,Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines[ J ]. Chest, 2004,126( suppl 1 ) :35S-62S.
  • 5Rich S, D' alonzo GE, Dantzker DR, et al. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension [ J ]. Am J Cardiol, 1985,55 ( 1 ) : 159-163.
  • 6Sitbon O, Humbert M,Jais X,et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension [ J ]. Circulation,2005, 111(23) :3105-3111.
  • 7Weir EK, Rubin LJ, Ayres SM, et al. The acute administration of vasodilator in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension [ J ]. Am Rev Respir Dis, 1989,140(6) :1623-1630.
  • 8Guillinta P, Peterson KL, Ben-Yehuda O. Cardiac catheterization techniques in pulmonary- hypertension [ J ]. Cardiol Clin ,2004,22 ( 3 ) :401 -415.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部